1. Home
  2. MLTX vs LMND Comparison

MLTX vs LMND Comparison

Compare MLTX & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • LMND
  • Stock Information
  • Founded
  • MLTX 2021
  • LMND 2015
  • Country
  • MLTX Switzerland
  • LMND United States
  • Employees
  • MLTX N/A
  • LMND N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • LMND Property-Casualty Insurers
  • Sector
  • MLTX Health Care
  • LMND Finance
  • Exchange
  • MLTX Nasdaq
  • LMND Nasdaq
  • Market Cap
  • MLTX 2.8B
  • LMND 2.8B
  • IPO Year
  • MLTX N/A
  • LMND 2020
  • Fundamental
  • Price
  • MLTX $52.40
  • LMND $48.94
  • Analyst Decision
  • MLTX Strong Buy
  • LMND Hold
  • Analyst Count
  • MLTX 7
  • LMND 11
  • Target Price
  • MLTX $74.83
  • LMND $32.91
  • AVG Volume (30 Days)
  • MLTX 497.4K
  • LMND 2.8M
  • Earning Date
  • MLTX 08-05-2025
  • LMND 08-05-2025
  • Dividend Yield
  • MLTX N/A
  • LMND N/A
  • EPS Growth
  • MLTX N/A
  • LMND N/A
  • EPS
  • MLTX N/A
  • LMND N/A
  • Revenue
  • MLTX N/A
  • LMND $600,700,000.00
  • Revenue This Year
  • MLTX N/A
  • LMND $37.43
  • Revenue Next Year
  • MLTX N/A
  • LMND $50.36
  • P/E Ratio
  • MLTX N/A
  • LMND N/A
  • Revenue Growth
  • MLTX N/A
  • LMND 27.51
  • 52 Week Low
  • MLTX $31.42
  • LMND $14.90
  • 52 Week High
  • MLTX $58.26
  • LMND $53.85
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 54.60
  • LMND 63.41
  • Support Level
  • MLTX $51.08
  • LMND $45.35
  • Resistance Level
  • MLTX $53.78
  • LMND $52.38
  • Average True Range (ATR)
  • MLTX 2.27
  • LMND 2.93
  • MACD
  • MLTX -0.42
  • LMND 1.15
  • Stochastic Oscillator
  • MLTX 55.43
  • LMND 79.38

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.

Share on Social Networks: